Olenox Industries completes acquisition of PsyLinks Neurotech for $500,000 in stock

Olenox Industries Inc.

Olenox Industries Inc.

OLOX

0.00
  • Olenox completed its acquisition of PsyLinks Neurotech, an applied intelligence and neurotechnology company focused on operational data analytics.
  • Deal terms: all outstanding PsyLinks shares exchanged for about $500,000 of Olenox restricted common stock.
  • PsyLinks will operate as a wholly owned subsidiary, adding applied AI and data analytics capabilities to Olenox’s technology and digital infrastructure strategy.
  • PsyLinks founders Michael McLaren-Gradinaru and Ford Burles joined Olenox as vice president of technology and vice president of product development.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Olenox Industries Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202607130830ACCESSWRNAPR_____1190053) on July 13, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.